Edwards Lifesciences Corp (EW)
91.41
+0.33
(+0.36%)
USD |
NYSE |
Jun 26, 15:15
Edwards Lifesciences Research and Development Expense (Annual): 1.072B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.072B |
| December 31, 2022 | 945.20M |
| December 31, 2021 | 903.10M |
| December 31, 2020 | 760.70M |
| December 31, 2019 | 752.70M |
| December 31, 2018 | 622.20M |
| December 31, 2017 | 552.60M |
| December 31, 2016 | 476.70M |
| December 31, 2015 | 382.90M |
| December 31, 2014 | 356.70M |
| December 31, 2013 | 323.00M |
| December 31, 2012 | 291.30M |
| December 31, 2011 | 246.30M |
| Date | Value |
|---|---|
| December 31, 2010 | 204.40M |
| December 31, 2009 | 175.50M |
| December 31, 2008 | 139.20M |
| December 31, 2007 | 122.30M |
| December 31, 2006 | 114.20M |
| December 31, 2005 | 99.00M |
| December 31, 2004 | 87.00M |
| December 31, 2003 | 72.80M |
| December 31, 2002 | 65.20M |
| December 31, 2001 | 55.00M |
| December 31, 2000 | 55.00M |
| December 31, 1999 | 55.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
752.70M
Minimum
2019
1.072B
Maximum
2023
886.70M
Average
903.10M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Becton Dickinson & Co | 1.237B |
| Align Technology Inc | 346.83M |
| Steris PLC | 103.68M |
| Abbott Laboratories | 2.741B |
| Boston Scientific Corp | 1.414B |